Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Wall Street
Price Targets
DRREDDY Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for DRREDDY is 6 041.653 INR with a low forecast of 3 954.15 INR and a high forecast of 7 124.25 INR.
Operating Income
Forecast
Operating Income Estimate
Dr Reddy's Laboratories Ltd
For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's operating income is 9%. The projected CAGR for the next 4 years is 9%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DRREDDY's stock price target?
Price Target
6 041.653
INR
According to Wall Street analysts, the average 1-year price target for DRREDDY is 6 041.653 INR with a low forecast of 3 954.15 INR and a high forecast of 7 124.25 INR.
What is Dr Reddy's Laboratories Ltd's Revenue forecast?
Projected CAGR
9%
For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's revenue is 6%. The projected CAGR for the next 4 years is 9%.
What is Dr Reddy's Laboratories Ltd's Operating Income forecast?
Projected CAGR
9%
For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's operating income is 9%. The projected CAGR for the next 4 years is 9%.
What is Dr Reddy's Laboratories Ltd's Net Income forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's net income is 9%. The projected CAGR for the next 4 years is 7%.